| Framingham predicted risk with eGFR by MDRD equation |  | ||||
---|---|---|---|---|---|---|
Framingham predicted risk without eGFR | < 15% | 15-30% | ≥ 30% | Reclassified higher risk | Reclassified lower risk | Correctly reclassified |
Participants who experienced ASVD hospitalization or death (n = 352) | ||||||
< 15% | 0 | 3 | 0 | Â | Â | Â |
15-30% | 6 | 124 | 23 | 26 (7.4%) | 23 (6.5%) | 3 (0.9%) |
≥ 30% | 0 | 17 | 179 |  |  |  |
Participants who did not experience ASVD hospitalization or death (n = 852) | ||||||
< 15% | 14 | 9 | 0 | Â | Â | Â |
15-30% | 34 | 439 | 50 | 59 (6.9%) | 102 (12.0%) | 43 (5.0%) |
≥ 30% | 3 | 65 | 238 |  |  |  |